Xiao-bo Wang

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Severity and Prognosis After Severe Traumatic Brain Injury: A Prospective Observational Study.

Utility of Serum Growth Arrest-Specific Protein 6 as a Biomarker of Severity and Prognosis After Severe Traumatic Brain Injury: A Prospective Observational Study.

Journal: Neuropsychiatric disease and treatment

Published: April 30, 2022

Radiomics-based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and influenza A infected pneumonia.

Radiomics-based model for accurately distinguishing between severe acute respiratory syndrome associated coronavirus 2 (SARS-CoV-2) and influenza A infected pneumonia.

Journal: MedComm

Published: May 18, 2020

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.

Journal: Gut

Published: April 28, 2020

A Case Series of Recurrent Viral RNA Positivity in Recovered COVID-19 Chinese Patients.

A Case Series of Recurrent Viral RNA Positivity in Recovered COVID-19 Chinese Patients.

Journal: Journal of general internal medicine

Published: April 22, 2020

Letter to the Editor: Obesity hypoventilation syndrome and severe COVID-19.

Letter to the Editor: Obesity hypoventilation syndrome and severe COVID-19.

Journal: Metabolism: clinical and experimental

Published: April 19, 2020

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.

Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis.

Journal: Journal of hepatology

Published: April 14, 2020

Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.

Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.

Journal: Journal of gastroenterology and hepatology

Published: April 08, 2020

Metabolic-associated fatty liver disease is associated with severity of COVID-19.

Metabolic-associated fatty liver disease is associated with severity of COVID-19.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 04, 2020

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease.

Journal: Metabolism: clinical and experimental

Published: April 02, 2020

Obesity Is a Risk Factor for Greater COVID-19 Severity.

Obesity Is a Risk Factor for Greater COVID-19 Severity.

Journal: Diabetes care

Published: March 31, 2020

Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection.

Establishment and Validation of SSCLIP Scoring System to Estimate Survival in Hepatocellular Carcinoma Patients Who Received Curative Liver Resection.

Journal: PloS one

Published: October 29, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026